Should You Buy Markel Stock (MKL) on the Dip?
Key PointsMarkel has delivered underwhelming underwriting results lately.
Markel (MKL) shares experienced a 13% drop year-to-date on October 23, prompting questions about whether it is a suitable time to invest in the company. Markel is often compared to Berkshire Hathaway due to its insurance focus, but there are notable differences. Like Berkshire, Markel primarily operates in the insurance sector, using its capital to invest in or acquire other companies.
Consequently, Markel holds stakes in various businesses, including industrial bakery equipment, ornamental plants, and precast concrete. Over the past 30 years, an investment of $10,000 in Markel would now be worth approximately $220,000, representing an average annual gain of 10.9%. This performance outpaces the S&P 500's average annual gain of 8.7% during the same period, which would have grown $10,000 to around $124,000.
Although Markel has faced challenges in recent years, with average annual gains lagging behind those of Berkshire Hathaway, the company's shares appear reasonably priced at current levels. However, the author is hesitant to invest due to the company's underwhelming recent performance and the stock's exposure to market fluctuations.
Furthermore, Markel does not offer dividends, aligning with the author's preference for income-generating stocks. While Markel could continue to excel in the future, the author suggests exploring other investment opportunities currently deemed more attractive.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
